See also this year's filing and all EDGAR filings for this company.
PDF Report 0001356857_2013_Trius_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001356857, Trius Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 73,981,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 990,000 |
| 3 | remainder_Assets | 303,000 |
| 4 | LiabilitiesCurrent | 18,487,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,395,000 |
| 9 | ResearchAndDevelopmentExpense | 69,023,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 27,185,000 |
| 12 | remainder_NetIncome | 3,305,000 |
| 13 | remainder_ComprehensiveNetIncome | 2,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 75,274,000 |
| 1 | Liabilities | 18,487,000 |
| 2 | Expenses | 84,418,000 |
| 3 | Revenues | 27,185,000 |
| 4 | StockholdersEquity | 56,787,000 |
| 5 | NetIncome | -53,928,000 |
| 6 | ComprehensiveNetIncome | -53,927,000 |
| 7 | BaseVar | 104,335,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.49 |
| 9 | EconomicCapitalRatio | 2.67 |
Edgar->Model Mapping
Feature Distribution
Change over Time
